Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome

Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome

Bibliographic Details
Main Authors:	Sérgio de A. Nishioka, Marcelo S. Ferreira, Ademir Rocha, Marcius K. N. Burgarelli, Arnaldo M. Silva, Maria Irma S. Duarte, Fernando C. Schmitt
Format:	Article
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 1993-09-01
Series:	Memórias do Instituto Oswaldo Cruz.
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761993000300022

Similar Items

Reactivation of Chagas' disease leading to the diagnosis of acquired immunodeficiency syndrome
by: Santos Eder de Oliveira, et al.
Published: (2002-01-01)

Reactivation of Chagas' disease leading to the diagnosis of acquired immunodeficiency syndrome
by: Eder de Oliveira Santos, et al.

Adverse drug reactions to benznidazole in Chagas disease: management and successful desensitization
by: M, et al.
Published: (2020-08-01)

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole.
by: Carlos Robello, et al.
Published: (2019-01-01)

Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole.
by: Carlos Robello, et al.
Published: (2019-01-01)

The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease
by: Mohamed Amin Ghobadifar, et al.
Published: (2014-10-01)

Trypanosoma cruzi meningoencephalitis and myocarditis in a patient with acquired immunodeficiency syndrome Meningoencefalite e miocardite por Trypanosoma cruzi em paciente com síndrome da imunodeficiência adquirida
by: Ademir Rocha, et al.
Published: (1993-04-01)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Benznidazole as Prophylaxis for Chagas Disease Infection Reactivation in Heart Transplant Patients: A Case Series in Brazil
by: Joao Manoel Rossi Neto, et al.
Published: (2020-08-01)

Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017-09-01)

Hepatic changes by benznidazole in a specific treatment for Chagas disease.
by: Tycha Bianca Sabaini Pavan, et al.
Published: (2018-01-01)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
by: Eleonora Lima Alves Cunha, et al.
Published: (2019-01-01)

Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.
by: Claudia Magalhães Calvet, et al.
Published: (2020-09-01)

Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole
by: Lucas A. M. Franco, et al.
Published: (2021-02-01)

Elevated IL-17 levels and echocardiographic signs of preserved myocardial function in benznidazole-treated individuals with chronic Chagas’ disease
by: Edmundo J.N. Camara, et al.
Published: (2019-02-01)

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.
by: Kota Yoshioka, et al.
Published: (2020-06-01)

Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
by: Lívia de Figueiredo Diniz, et al.
Published: (2013-01-01)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.
by: Abilio Augusto Fragata-Filho, et al.
Published: (2016-03-01)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil.
by: Ariela Mota Ferreira, et al.
Published: (2016-01-01)

Desenvolvimento de método analítico por CLAE em comprimidos de Benznidazol para a Doença de Chagas Development of an hplc analytical method for benznidazol tablets for the treatment of chagas disease
by: Ana Luiza Maurer da Silva, et al.
Published: (2007-10-01)

Agreement between premortem and postmortem diagnoses in patients with acquired immunodeficiency syndrome observed at a brazilian teaching hospital
by: Aércio Sebastião BORGES, et al.
Published: (1997-07-01)

Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole
by: Jair Téllez, et al.
Published: (2019-05-01)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Benznidazole
by: Bruno Dacunha-Marinho, et al.
Published: (2008-03-01)

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
by: Marcela S Rial, et al.
Published: (2017-12-01)

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
by: Renata Sesti-Costa, et al.
Published: (2014-10-01)

Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report
by: Valeria Rita Corrêa, et al.
Published: (2014-06-01)

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
by: Elena Aguilera, et al.

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
by: Clareci Silva Cardoso, et al.
Published: (2018-11-01)

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
by: Leticia L Niborski, et al.
Published: (2016-06-01)

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
by: Girley Francisco Machado-de-Assis, et al.
Published: (2013-11-01)

Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions
by: João Paulo Ramalho Correia, et al.

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
by: Tassiane Assíria Fontes Martins, et al.
Published: (2015-01-01)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
by: Luis Eduardo Echeverría, et al.

Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease.
by: Mario J Olivera, et al.
Published: (2017-01-01)

Sistemas de vetorização do benznidazol para o tratamento da doença de Chagas
by: Lamartine Soares Sobrinho, José
Published: (2014)

Reações adversas em pacientes com doença de Chagas tratados com benzonidazol, no Estado do Ceará Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará
by: Vânia Maria Oliveira de Pontes, et al.
Published: (2010-04-01)

Usefulness of real-time PCR during follow-up of patients treated with Benznidazole for chronic Chagas disease: Experience in two referral centers in Barcelona.
by: Elena Sulleiro, et al.
Published: (2020-02-01)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
by: Priscila Silva Grijó Farani, et al.
Published: (2021-07-01)

Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.
by: Ana Yecê das Neves Pinto, et al.
Published: (2013-01-01)